# US 2025/0367384 A1 · Medical injections and related devices and methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0367384 A1
- Document ID: US20250367384A1
- Status: Published application
- Kind: A1
- Application number: 19/206,223
- Filed: 2025-05-13
- Published: 2025-12-04
- Earliest claimed: 2024-05-14
- Assignees: Gilead Sciences, Inc.
- Applicants: Gilead Sciences, Inc.
- Inventors: Stephan Edward Augustyn; Walter Goodwin; William James Kirby; Finlay Knops-McKim; Daniel Milton Meruz; James Paul Oberhauser; Adam Toner; Alasdair Young
- Web page: https://patentgrep.com/patent/US20250367384A1

## CPC

- A61M 5/31541: {Means preventing setting of a dose beyond the amount remaining in the cartridge}
- A61M 5/3157: {Means providing feedback signals when administration is completed (A61M5/20 takes precedence)}
- A61K 9/0019: {Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00)}
- A61K 31/4439: containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole (nicotine A61K31/465)
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61M 5/2046: {Media being expelled from injector by gas generation, e.g. explosive charge}
- A61M 5/2053: {Media being expelled from injector by pressurised fluid or vacuum (for infusion A61M5/145, A61M5/155)}
- A61M 5/31511: {Piston or piston-rod constructions, e.g. connection of piston with piston-rod (A61M5/5066 takes precedence)}
- A61M 5/46: having means for controlling depth of insertion
- A61M 2205/3306: Optical measuring means
- A61M 2205/3368: Temperature
- A61M 2205/3576: with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M 2205/581: by audible feedback
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Systems, devices, and methods include an autoinjector including a housing; a needle arranged at a distal end of the housing; a container disposed within the housing and configured to contain medicament; and a plunger slidably disposed within the container. A plunger rod is configured to push the plunger through the container to dispense the medicament through the needle when the container contains medicament. The plunger rod includes one or more optical transmission regions. A mechanism is configured so that a dispensing movement of the plunger rod causes the mechanism to generate a first optical signal and transmit the first optical signal through at least one of the one or more optical transmission regions; and an optical sensor is configured to detect the first optical signal generated by the mechanism.

## Claims

### Claim 1

An autoinjector comprising:
a housing;
a needle arranged at a distal end of the housing;
a container disposed within the housing and configured to contain medicament;
a plunger slidably disposed within the container;
a plunger rod configured to push the plunger through the container to dispense the medicament through the needle when the container contains medicament, wherein the plunger rod comprises one or more optical transmission regions;
an optical emitter configured to emit a first optical signal through at least one of the one or more optical transmission regions of the plunger rod; and
an optical receiver configured to receive the first optical signal, wherein a dispensing movement of the plunger rod enables transmission of the first optical signal from the optical emitter through the at least one of the one or more optical transmission regions and to the optical receiver.

### Claim 2 (depends on 1)

The autoinjector of claim 1, wherein the first optical signal is indicative of dose progression.

### Claim 3

(canceled)

### Claim 4 (depends on 1)

The autoinjector of claim 1, wherein the medicament comprises lenacapavir or a pharmaceutically accepted salt thereof.

### Claim 5 (depends on 1)

The autoinjector of claim 1, wherein the autoinjector further comprises a gas canister assembly configured to release pressurized gas which, when released, provides a force acting on the plunger rod to push the plunger through the container.

### Claim 6 (depends on 1)

The autoinjector of claim 1, wherein the at least one of the one or more optical transmission regions comprises an aperture disposed within the plunger rod.

### Claim 7 (depends on 1)

The autoinjector of claim 1, wherein the at least one of the one or more optical transmission regions comprises an optically transparent region disposed within the plunger rod.

### Claim 8 (depends on 1)

The autoinjector of claim 1, wherein the plunger rod comprises a plurality of optical transmission regions and the plunger rod is configured to transmit a plurality of optical signals during the dispensing movement of the plunger rod.

### Claim at position 9

9-10. (canceled)

### Claim 11 (depends on 8)

The autoinjector of claim 8, wherein a first optical transmission region of the plurality of optical transmission regions is configured to indicate dose start of the medicament, and/or wherein a last optical transmission region of the plurality of optical transmission regions is configured to indicate dose end of the medicament.

### Claim 12

(canceled)

### Claim 13 (depends on 1)

The autoinjector of claim 1, further comprising:
an audible clicker comprising a ring surrounding the plunger rod, and wherein the ring comprises a deflectable protrusion configured to contact the plunger rod to produce one or more audible clicks during the dispensing movement of the plunger rod.

### Claim 14

(canceled)

### Claim 15 (depends on 13)

The autoinjector of claim 13, wherein the plunger rod comprises a ridged surface configured to contact the deflectable protrusion of the audible clicker during the dispensing movement of the plunger rod.

### Claim 16

(canceled)

### Claim 17 (depends on 1)

The autoinjector of claim 1, wherein each of the optical emitter and the optical receiver is, independently, disposed between a proximal end and a distal end of the housing.

### Claim 18 (depends on 17)

The autoinjector of claim 17, wherein the optical emitter comprises an infrared emitter, and/or wherein the optical receiver comprises an infrared receiver.

### Claim 19 (depends on 17)

The autoinjector of claim 17, further comprising an optical reflector configured to provide an optical path between the optical emitter and the optical receiver.

### Claim 20 (depends on 19)

The autoinjector of claim 19, wherein the optical reflector is disposed on a first surface within the housing, and wherein the optical emitter and the optical receiver are disposed on a second surface that opposes the first surface.

### Claim 21

(canceled)

### Claim 22 (depends on 17)

The autoinjector of claim 17, further comprising a first sensor disposed between a proximal end and a distal end of the housing, wherein the first sensor is configured to detect a first electrical signal generated by applying an insertion force to insert the needle into a user.

### Claim 23

(canceled)

### Claim 24 (depends on 22)

The autoinjector of claim 22, further comprising a second sensor disposed between a proximal end and a distal end of the housing, wherein the second sensor is configured to detect an ambient temperature in proximity to the container.

### Claim 25

(canceled)

### Claim 26 (depends on 1)

The autoinjector of claim 1, wherein the housing comprises an optically shielded housing, and/or wherein the housing further comprises an optically blocking label.

### Claim 27

(canceled)

### Claim 28

An autoinjector comprising:
a housing;
a needle arranged at a distal end of the housing;
a needle guard configured to expose the needle when an insertion force is applied to insert the needle into a user;
a container disposed within the housing and configured to contain medicament;
a plunger slidably disposed within the container;
a plunger rod configured to push the plunger through the container to dispense the medicament through the needle when the container contains medicament and when the needle is exposed, wherein the plunger rod comprises one or more optical transmission regions;
an optical mechanism configured to emit a first optical signal through at least one of the one or more optical transmission regions of the plunger rod and to receive the first optical signal, wherein a dispensing movement of the plunger rod enables transmission of the first optical signal; and
an electrical mechanism configured to contact a portion of the needle guard, wherein a compression movement of the needle guard generates a first electrical signal.

### Claim 29

(canceled)

### Claim 30

A method of detecting a dispensing movement of a plunger rod within an autoinjector, the method comprising:
detecting one or more optical signals of an optical emitter as the plunger rod moves during the dispensing movement, wherein the plunger rod comprises one or more optical transmission regions, and
wherein the dispensing movement of the plunger rod provides optical communication between the optical emitter and one or more transmission regions to transmit the one or more optical signals.

### Claim 31

(canceled)

### Claim 32 (depends on 30)

The method of claim 30, wherein the plunger rod comprises a plurality of optical transmission regions and the plunger rod is configured to transmit a plurality of optical signals during the dispensing movement of the plunger rod.

### Claim 33

(canceled)

### Claim 34 (depends on 32)

The method of claim 32, wherein a first optical transmission region of the plurality of optical transmission regions is configured to indicate dose start of a medicament, and/or wherein a last optical transmission region of the plurality of optical transmission regions is configured to indicate dose end of the medicament.

### Claim at position 34

35-36. (canceled)

### Claim 37 (depends on 30)

The method of claim 30, wherein the autoinjector further comprises an audible clicker, the audible clicker comprising a ring surrounding the plunger rod, and wherein the ring comprises a deflectable protrusion configured to contact the plunger rod and produce the one or more audible clicks during the dispensing movement of the plunger rod.

### Claim 38 (depends on 37)

The method of claim 37, wherein the plunger rod comprises a ridged surface configured to cause the deflectable protrusion of the audible clicker to deflect during the dispensing movement of the plunger rod.

### Claim at position 37

39-42. (canceled)

### Claim 43 (depends on 30)

The method of claim 30, further comprising detecting, by the first sensor, a first electrical signal generated by applying an insertion force to insert a needle into a user.

### Claim at position 39

44-45. (canceled)

### Claim 46 (depends on 30)

The method of claim 30, further comprising sending, via a wireless transfer protocol module, signals from a first sensor, if present, and a second sensor, if present, to a mobile device.

### Claim 47 (depends on 46)

The method of claim 46, further comprising displaying information about the dispensing movement on the mobile device.

### Claim 48 (depends on 30)

The method of claim 30, further comprising measuring a temperature of medicament within the autoinjector or an ambient temperature within the autoinjector using a temperature sensor.

### Claim 49 (depends on 48)

The method of claim 48, further comprising sending, via a wireless transfer protocol module, signals from the temperature sensor to a mobile device.

### Claim 50 (depends on 48)

The method of claim 48, further comprising displaying the temperature of the medicament or the ambient temperature on a mobile device; indicating that the temperature of the medicament or the ambient temperature is above a threshold temperature for use of the autoinjector; or both.

### Claim 51 (depends on 1)

A composition comprising lenacapavir or a pharmaceutically accepted salt thereof for use in the prevention or treatment of HIV, wherein the composition is administered via the autoinjector of claim 1.

### Claim 52 (depends on 1)

Use of lenacapavir or a pharmaceutically accepted salt thereof for the manufacture of a medicament for the prevention or treatment of HIV, wherein the prevention or treatment comprises administering the medicament via the autoinjector of claim 1.
